Jonathan Talamo resigned as Ocular Therapeutix Inc.'s chief medical officer, effective June 15.
Ocular Therapeutix chief medical officer resigns
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective